Lyell Immunopharma (LYEL) Shares Issued (2020 - 2021)

Lyell Immunopharma (LYEL) posted Shares Issued of $43.6 million for Q3 2021, up 3.28% sequentially from $42.2 million in Q2 2021.

Lyell Immunopharma (LYEL) Shares Issued (2020 - 2021) Analysis & Trends

Lyell Immunopharma has reported Shares Issued for 2 years, with the latest figure at $43.6 million in Q3 2021.

Quarterly Shares Issued changed N/A year-over-year to $43.6 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $43.6 million (changed N/A YoY) and the FY2020 annual result came in at $34.4 million, changed N/A from the prior year.
Shares Issued improved to $43.6 million in Q3 2021 per LYEL's latest filing, from $42.2 million in the prior quarter.
Over five years, Shares Issued peaked at $43.6 million in Q3 2021 and troughed at $34.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	18.36 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Lyell Immunopharma	326.39 Mn	326.39 Mn	-	-

Download Data